Abstract
PURPOSE: Patients with unresectable, locally advanced rectal cancer are reported to have a dismal prognosis. The aim of this study was to analyze the effect of combined-modality therapy on clinical outcome. METHODS: From March 1990 to December 1997, 43 patients (28 males; median age, 62 years; median follow-up, 74 months) with locally advanced (T4 and/or N3) nonmetastatic rectal cancer received external-beam radiation (23.6 plus 23.6 Gy (split course), 8 patients; 45 Gy, 35 patients) plus 5-fluorouracil (96-hour continuous infusion, Days 1–4, at 1,000 mg/m2/day) and mitomycin C (10 mg/m2, intravenous bolus, Day 1). Concomitant chemotherapy was repeated at the beginning of the second course (split-course group) or in the last week of radiotherapy (continuous-course group). After 6 to 8 weeks, patients were evaluated for surgical resection and intraoperative radiation therapy (10 to 15 Gy). Thereafter, adjuvant chemotherapy (5-fluorouracil plus leucovorin, 6–9 courses) was prescribed. RESULTS: During chemoradiation, 5 patients (11.6 percent) developed Grade 3 to 4 hematologic toxicity. After chemoradiation, 29 patients (67.4 percent) had an objective clinical response (complete response, 2.3 percent; partial response, 65.1 percent). Thirty-eight patients underwent radical surgery (anterior resection, 24 patients; abdominoperineal resection, 14 patients; intraoperative radiation therapy boost on the tumor bed, 19 patients), and 2 patients had partial tumor resection. No perioperative deaths occurred in the patient group. Five-year survival and local control rates were 59.9 and 69.1 percent, respectively. Distant metastasis occurred in 44.2 percent of patients. Statistically significant relationships between intraoperative radiation therapy and local control (P = 0.0104), radical surgery and survival (P = 0.0120), and adjuvant chemotherapy and disease-free survival (P = 0.0112) were observed. CONCLUSIONS: Our data suggest that combined-modality therapy was relatively well tolerated and resulted in good local control and survival. With regard to the impact of surgical resection on survival, additional studies aimed at improving the local response rate are necessary, whereas the positive impact of intraoperative radiotherapy on local control appears to justify the inclusion of this therapeutic modality in prospective multi-institutional trials.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
KM Tveit JN Wiig DR Olsen A Storaas JP Pousen KE Giercksky (1997) ArticleTitleCombined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer Radiother Oncol 44 277–282
M Aleksic N Hennes B Ulrich (1998) ArticleTitleSurgical treatment of locally advanced rectal cancer. Options and strategies Dig Surg 15 342–346
NR Ahmad D Nagle (1997) ArticleTitleLong-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer Br J Surg 84 1445–1448
TD Nguyen C Cassardeaux F Mallet (1996) ArticleTitlePreoperative radiotherapy in rectal cancer. Are all protocols comparable? Int J Radiat Oncol Biol Phys 36 987–988
R Engenhart-Cabillic J Debus FJ Prott et al. (1998) ArticleTitleUse of neutron therapy in the management of locally advanced nonresectable primary or recurrent rectal cancer Recent Results Cancer Res 150 113–124
B Rau P Wust P Hohenberger et al. (1998) ArticleTitlePreoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer Ann Surg 227 380–389
P Wust B Rau J Gellerman et al. (1998) ArticleTitleRadiochemotherapy and hyperthermia in the treatment of rectal cancer Recent Results Cancer Res 146 175–191
LB Harrison BD Minsky WE Enker et al. (1998) ArticleTitleHigh dose rate intraoperative radiation therapy (HDH-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer Int J Radiat Oncol Biol Phys 42 325–330
LL Gunderson H Nelson JA Martenson et al. (1997) ArticleTitleLocally advanced primary colorectal cancer Int J Radiat Oncol Biol Phys 37 601–614
HK Kim JM Jessup CJ Beard et al. (1997) ArticleTitleLocally advanced rectal carcinoma Int J Radiat Oncol Biol Phys 38 777–783
BM Nakfoor CG Willett PC Shellito DS Kaufman WJ Daly (1998) ArticleTitleThe impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer Ann Surg 228 194–200
CG Willett PC Shellito JE Tepper R Eliseo K Convery WC Wood (1991) ArticleTitleIntraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoidal carcinoma J Clin Oncol 9 843–849
B Movsas AL Hanlon R Lanciano et al. (1998) ArticleTitlePhase I escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 42 43–50
M Haghbin B Sishy J Hinson (1988) ArticleTitleCombined modality preoperative therapy in poor prognostic rectal adenocarcinoma Radiother Oncol 13 75–81
SJ Burke BC Percapio DC Knight EM Kwasnik (1998) ArticleTitleCombined preoperative radiation and mytomicin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma J Am Coll Surg 187 164–170
BD Minsky AM Cohen WE Enker et al. (1997) ArticleTitlePreoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced inresectable rectal cancer Int J Radiat Oncol Biol Phys 37 289–295
GM Videtic BJ Fisher FE Perera et al. (1998) ArticleTitlePreoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer Int J Radiat Oncol Biol Phys 42 319–324
PM Busse A Ng A Recht (1998) ArticleTitleInduction therapy for rectal cancer Semin Surg Oncol 15 120–125
BD Minsky (1997) ArticleTitleThe role of radiation therapy in rectal cancer Semin Oncol 24 18–29
ND Nigro VK Vaitkevicius B Considine (1974) ArticleTitleCombined therapy for cancer of the anal canal Dis Colon Rectum 17 354–358
L Sofo C Ratto GB Doglietto et al. (1996) ArticleTitleIntraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study Dis Colon Rectum 39 1396–1403
AB Miller B Hoogstraten M Staquet A Winkler (1981) ArticleTitleReporting results of cancer treatment Cancer 47 207–214
FL Kaplan P Meier (1958) ArticleTitleNon parametric estimation from incomplete observations Am J Stat Assoc 53 457–481
R Peto J Peto (1972) ArticleTitleAsimptomatically efficient rank invariant procedures J R Stat Soc 135 185–207
DR Cox (1972) ArticleTitleRegression model and life tables J Royal Stat Soc Series B 34 187–220
M Mohiuddin WF Regine WJ John et al. (2000) ArticleTitlePreoperative chemoradiation in fixed distal rectal cancer Int J Radiat Oncol Biol Phys 46 883–888
V Valentini AG Morganti A De Franco et al. (1999) ArticleTitleChemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma. Prognostic factors and long term outcome Cancer 86 2612–2624
NA Janjan VS Khoo TA Rich et al. (1998) ArticleTitleLocally advanced rectal cancer Radiology 206 131–136
R Farouk H Nelson LL Gunderson (1997) ArticleTitleAggressive multimodality treatment for locally advanced irresectable rectal cancer Br J Surg 84 741–749
A Tannapfel S Nusslein R Fietkau A Katalinic F Kockerling C Wittekind (1998) ArticleTitleApoptosis, proliferation, bax and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 41 585–591
P Luna-Perez EL Arriola Y Cuadra I Alvarado A Quintero (1998) ArticleTitleP53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma Ann Surg Oncol 5 203–208
Author information
Authors and Affiliations
About this article
Cite this article
Ratto, C., Valentini, V., Morganti, A.G. et al. Combined-Modality Therapy in Locally Advanced Primary Rectal Cancer. Dis Colon Rectum 46, 59–67 (2003). https://doi.org/10.1007/s10350-004-6497-1
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6497-1